Myositis ossificans progressiva, left hand
ICD-10 M61.142 is a billable code used to indicate a diagnosis of myositis ossificans progressiva, left hand.
Myositis ossificans progressiva (MOP) is a rare genetic disorder characterized by the abnormal formation of bone in muscles, tendons, and other connective tissues. This condition is caused by mutations in the ACVR1 gene, which plays a crucial role in bone development and repair. Patients with MOP experience progressive muscle stiffness and weakness, often leading to significant functional impairment. The left hand may be specifically affected, resulting in reduced mobility and dexterity. Symptoms typically begin in childhood or early adulthood and can be triggered by trauma or injury, although they may also occur spontaneously. Diagnosis is primarily clinical, supported by imaging studies that reveal calcification in soft tissues. Management focuses on symptomatic relief and physical therapy, as surgical intervention is often complicated by the risk of further ossification. Understanding the implications of this condition is essential for accurate coding and treatment planning.
Detailed clinical notes on symptoms, progression, and treatment response.
Patients presenting with muscle stiffness and pain, particularly after trauma.
Documentation should include family history and any genetic testing performed.
Genetic testing results and family pedigree.
Patients with a family history of myositis ossificans or unexplained ossification.
Ensure that genetic counseling notes are included in the medical record.
Used for follow-up visits for management of myositis ossificans.
Document history, examination findings, and treatment plan.
Rheumatology may require additional details on functional status.
Myositis ossificans progressiva is a rare genetic disorder characterized by the abnormal formation of bone in muscles and connective tissues, leading to stiffness and functional impairment.
